← Back to Search

MRI for Brain Ischemia (CSI Trial)

N/A
Recruiting
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over 12 weeks for phase one with week-by-week randomization to imaging modality, then 2 weeks of randomization per-patient
Awards & highlights

CSI Trial Summary

The purpose of this study is to test feasibility of a comparative effectiveness framework for acute stroke imaging using prospective electronic health data. This is a prospective, cohort feasibility study of patients presenting to the Emergency Department with suspected acute ischemic stroke. The clinical stroke team will not be blinded to the imaging modality given the nature and purpose of the interventions/imaging. Knowledge of the imaging modality used and the knowledge gained from the resulting data will need to be considered for treatment decisions. Blinding will be maintained for data abstraction and analyses. Analysis will be on an "intent-to-scan" basis and all qualifying patients will be included in their assigned cohort.

CSI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over 12 weeks for phase one with week-by-week randomization to imaging modality, then 2 weeks of randomization per-patient
This trial's timeline: 3 weeks for screening, Varies for treatment, and over 12 weeks for phase one with week-by-week randomization to imaging modality, then 2 weeks of randomization per-patient for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
compliance

CSI Trial Design

2Treatment groups
Experimental Treatment
Group I: MRIExperimental Treatment2 Interventions
patients assigned to MRI
Group II: CTExperimental Treatment2 Interventions
patients assigned to CT
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MRI
2009
Completed Phase 2
~1370
CT
2017
Completed Phase 3
~3200

Find a Location

Who is running the clinical trial?

Lone Star Stroke Research ConsortiumUNKNOWN
1 Previous Clinical Trials
200 Total Patients Enrolled
University of Texas at AustinLead Sponsor
353 Previous Clinical Trials
80,644 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~400 spots leftby Apr 2025